OpenAI has officially entered the specialized science race with GPT-Rosalind, a frontier reasoning model designed to slash the 10-15 year timeline of drug discovery through advanced biochemistry and genomic analysis. The post OpenAI Launches GPT-Rosalind: Its First Life Sciences AI Model Built to Accelerate Drug Discovery and Genomics Research appeared first on MarkTechPost.